Contineum Therapeutics, Inc.
CTNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855175
In the last 90 days, Contineum Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $500.6M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding Contineum Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 52 | 62 | +10 |
| Shares | 13.7M | 15.8M | +2.07M (+15.1%) |
| Value | $258.4M | $231.1M | −$27.3M (−10.6%) |
New holders (13)
Institutions that held Contineum Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Red Tree Management, LLC | 638,158 | $9.35M | 6.15% |
| StemPoint Capital LP | 265,833 | $3.89M | 0.98% |
| Schonfeld Strategic Advisors LLC | 125,995 | $1.85M | 0.01% |
| Janus Henderson Group PLC | 68,320 | $1.00M | 0.00% |
| Goldman Sachs Group Inc | 26,365 | $386.2K | 0.00% |
| Deutsche Bank AG | 16,079 | $235.6K | 0.00% |
| Strategies Wealth Advisors, LLC | 25,000 | $206.3K | 0.03% |
| Nuveen Asset Management, LLC | 13,307 | $194.9K | 0.00% |
| Marshall Wace, LLP | 10,836 | $158.7K | 0.00% |
| MetLife Investment Management | 7,029 | $103.0K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 1,396 | $20.5K | 0.00% |
| GAMMA Investing LLC | 80 | $1.17K | 0.00% |
| EverSource Wealth Advisors, LLC | 3 | $44 | 0.00% |
Sold out (3)
Institutions that held Contineum Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Driehaus Capital Management LLC | 66,667 | $1.28M |
| Board of Trustees of The Leland Stanford Junior University | 38,869 | $744.0K |
| HRT Financial LP | 11,142 | $213.0K |